Warnyta Minnaard
If the practitioner doesn’t know where the primary tumor is located, they cannot offer a targeted treatment plan, and nor can they give the patient an estimate of their life expectancy.
Back to newsMore news
Unraveling of genetic mechanism behind tumor formation may improve targeted treatment for cancer patients
Genetic alterations in the FGFR2 gene occur in various cancer types and represent a promising target for therapies. However, clinical …
Hartwig Medical Foundation welcomes new managing director
Hartwig Medical Foundation is pleased to announce that Robert Jan Lamers has joined the organization as its new managing director, …
Pay attention to the ethical aspects of data sharing
Frank van Wijck, science journalist Eline Bunnik is an associate professor at the Department of Medical Ethics, Philosophy and History of …
We are proud that we succeeded in implementing the complete DNA test in standard of care diagnostics, together with Hartwig Medical Foundation. Moreover, the test produces vital information for a learning healthcare system in oncology. We will be able to treat future patients even more effectively.